Old Web
English
Sign In
Acemap
>
authorDetail
>
Sabine Sperka
Sabine Sperka
GPC Biotech
Lymphoma
Immunology
Toxicity
Medicine
Pharmacokinetics
2
Papers
7
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Clinical safety and pharmacological profile of the HLA-DR antibody 1D09C3 in patients with B cell chronic lymphocytic leukemia and lymphoma: results from a phase I study.
2012
Cancer Immunology, Immunotherapy
Carmen D. Schweighofer
Armin Tuchscherer
Sabine Sperka
Thorsten Meyer
Benno Rattel
Sandra Stein
Semra Ismail
Thomas Elter
Peter Staib
Marcel Reiser
Michael Hallek
Show All
Source
Cite
Save
Citations (6)
Two Phase I Open-Label Studies of the Fully Human HLA-DR-Specific IgG 4 Monoclonal Antibody 1D09C3 in Patients with Relapsed and/or Refractory B-Cell Lymphoproliferative Neoplasias on a Weekly and Bi-Weekly Dosing Scheme.
2006
Blood
Alessandro M. Gianni
Carmelo Carlo-Stella
Anna Guidetti
Michael Hallek
Carmen D. Schweighofer
Clemens-M. Wendtner
Michele Ghielmini
Erica Lerch
Sabine Sperka
Douglas Greene
Oliver Krieter
F. E. Nathan
Michael E. Petrone
Show All
Source
Cite
Save
Citations (1)
1